» Articles » PMID: 25568888

Distinctive Distribution of Lymphocytes in Unruptured and Previously Untreated Brain Arteriovenous Malformation

Overview
Date 2015 Jan 9
PMID 25568888
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To test the hypothesis that lymphocyte infiltration in brain arteriovenous malformation (bAVM) is not associated with iron deposition (indicator of microhemorrhage).

Methods: Sections of unruptured, previously untreated bAVM specimens (n=19) were stained immunohistochemically for T-lymphocytes (CD3), B-lymphocytes (CD20), plasma cells (CD138) and macrophages (CD68). Iron deposition was assessed by hematoxylin and eosin and Prussian blue stains. Superficial temporal arteries (STA) were used as control.

Results: Both T lymphocytes and macrophages were present in unruptured, previously untreated bAVM specimens, whereas few B cells and plasma cells were detected. Iron deposition was detected in 8 specimens (42%; 95% confidence interval =20-67%). The samples with iron deposition tended to have more macrophages than those without (666±313 vs 478±174 cells/mm; P=0.11). T-cells were clustered on the luminal side of the endothelial surface, on the vessel-wall, and in the perivascular regions. There was no correlation between T lymphocyte load and iron deposition (P=0.88). No macrophages and lymphocytes were detected in STA controls.

Conclusions: T-lymphocytes were present in bAVM specimens. Unlike macrophages, the load and location of T-lymphocytes were not associated with iron deposition, suggesting the possibility of an independent cell-mediated immunological mechanism in bAVM pathogenesis.

Citing Articles

An Updated Review on the Pathogenesis of Brain Arteriovenous Malformations and Its Therapeutic Targets.

Ota T J Neuroendovasc Ther. 2025; 19(1).

PMID: 39958460 PMC: 11826344. DOI: 10.5797/jnet.ra.2024-0008.


Risk assessment for rupture of brain arteriovenous malformations using high-resolution black-blood magnetic resonance imaging: a single-center case series.

Filho J, Lucifero A, Ahumada-Vizcaino J, Mulato J, Marussi V, de Siqueira Campos C Neurosurg Rev. 2024; 47(1):840.

PMID: 39523229 DOI: 10.1007/s10143-024-03084-7.


CNS resident macrophages enhance dysfunctional angiogenesis and circulating monocytes infiltration in brain arteriovenous malformation.

Ma L, Zhu X, Tang C, Pan P, Yadav A, Liang R J Cereb Blood Flow Metab. 2024; 44(6):925-937.

PMID: 38415628 PMC: 11318399. DOI: 10.1177/0271678X241236008.


Increased Collagen I/Collagen III Ratio Is Associated with Hemorrhage in Brain Arteriovenous Malformations in Human and Mouse.

Shabani Z, Schuerger J, Zhu X, Tang C, Ma L, Yadav A Cells. 2024; 13(1).

PMID: 38201296 PMC: 10778117. DOI: 10.3390/cells13010092.


The Role and Therapeutic Implications of Inflammation in the Pathogenesis of Brain Arteriovenous Malformations.

Ricciardelli A, Robledo A, Fish J, Kan P, Harris T, Wythe J Biomedicines. 2023; 11(11).

PMID: 38001877 PMC: 10669898. DOI: 10.3390/biomedicines11112876.


References
1.
Hasan D, Amans M, Tihan T, Hess C, Guo Y, Cha S . Ferumoxytol-enhanced MRI to Image Inflammation within Human Brain Arteriovenous Malformations: A Pilot Investigation. Transl Stroke Res. 2012; 3(Suppl 1):166-73. PMC: 3445332. DOI: 10.1007/s12975-012-0172-y. View

2.
Halim A, Singh V, Johnston S, Higashida R, Dowd C, Halbach V . Characteristics of brain arteriovenous malformations with coexisting aneurysms: a comparison of two referral centers. Stroke. 2002; 33(3):675-9. DOI: 10.1161/hs0302.104104. View

3.
Aziz M, Takagi Y, Hashimoto N, Miyamoto S . Activation of nuclear factor κB in cerebral arteriovenous malformations. Neurosurgery. 2010; 67(6):1669-79. DOI: 10.1227/NEU.0b013e3181fa00f1. View

4.
Redekop G, Elisevich K, Gaspar L, Wiese K, Drake C . Conventional radiation therapy of intracranial arteriovenous malformations: long-term results. J Neurosurg. 1993; 78(3):413-22. DOI: 10.3171/jns.1993.78.3.0413. View

5.
Guo Y, Saunders T, Su H, Kim H, Akkoc D, Saloner D . Silent intralesional microhemorrhage as a risk factor for brain arteriovenous malformation rupture. Stroke. 2012; 43(5):1240-6. PMC: 3335931. DOI: 10.1161/STROKEAHA.111.647263. View